Form D · Other Health Care
Sonogenix, Inc.
Belmont, CA · CIK 0001527202
Offering snapshot reported Aug 2, 2011 · SEC filing
- Reported sold
- $250K Offering amount: $650K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2011 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-163838
Source: Form D, filed Aug 2, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Claire Andrews | Director, Executive |
| Michael Dae | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1714 Notre Dame Avenue
Belmont, CA, 94002
Belmont, CA, 94002